Compare CYTK & SPXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYTK | SPXC |
|---|---|---|
| Founded | 1997 | 1912 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 9.1B |
| IPO Year | 2004 | N/A |
| Metric | CYTK | SPXC |
|---|---|---|
| Price | $62.51 | $206.18 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 7 |
| Target Price | $78.94 | ★ $214.14 |
| AVG Volume (30 Days) | ★ 1.7M | 728.1K |
| Earning Date | 11-05-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 26.00 |
| EPS | N/A | ★ 4.69 |
| Revenue | $87,211,000.00 | ★ $2,161,500,000.00 |
| Revenue This Year | $361.33 | $16.08 |
| Revenue Next Year | $65.14 | $8.42 |
| P/E Ratio | ★ N/A | $43.24 |
| Revenue Growth | ★ 2609.26 | 12.60 |
| 52 Week Low | $29.31 | $115.00 |
| 52 Week High | $69.33 | $233.71 |
| Indicator | CYTK | SPXC |
|---|---|---|
| Relative Strength Index (RSI) | 49.62 | 44.19 |
| Support Level | $59.37 | $207.04 |
| Resistance Level | $63.80 | $226.31 |
| Average True Range (ATR) | 2.56 | 7.57 |
| MACD | -0.44 | -1.13 |
| Stochastic Oscillator | 42.46 | 9.88 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
SPX Technologies Inc supplies engineered heating, ventilation, and air conditioning, or HVAC, products, as well as detection and measurement technologies and power equipment. The company through two reportable segments. The HVAC segment which generates the majority of the revenue for the company, designs, manufactures, installs, and services cooling products, as well as heating and ventilation products. The detection and measurement technologies segment designs, manufactures, and installs underground pipe and cable locators and inspection equipment, bus-fare collection systems, and others. Geographically, the company has its operations in the United States, Canada, China, the United Kingdom, and Others.